Publication | Open Access

Minimal doses of a sequence-optimized transgene mediate high-level and long-term EPO expression in vivo: challenging CpG-free gene design

Systems BiologyEngineeringProtein ExpressionGenetic EngineeringLong-term Epo ExpressionMinimal DosesGene VectorGene ExpressionMedicineCell BiologyGenome EditingCell-free SystemsGene Transfer